-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 15-09-2023 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 PDF | 471.66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 15-09-2023 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 DOCX | 30.3 kB
-
2020-07-23 Guidance document viral vectors - Netherlands_V2.1 10-12-2019 2020-07-23 Guidance document viral vectors - Netherlands_V2.1 PDF | 311.38 kB
-
2020-07-23 Guidance document AAV vectors - Netherlands _V1.1 10-12-2019 2020-07-23 Guidance document AAV vectors - Netherlands _V1.1 PDF | 281.42 kB
-
-